Abcam opens new U.S.-based manufacturing facility

By The Science Advisory Board staff writers

July 13, 2021 -- Abcam has opened a new 100,000-sq-ft facility in Waltham, MA, to serve as a hub for its research and development (R&D) and commercial activities in the region.

The facility will more than double Abcam's capacity at its previous site in Cambridge, MA, and will eventually house about 300 employees, according to the company. The new site will increase the company's flexibility, scale, and capacity in R&D, production, distribution, and customer service for biopharma partners and life science researchers.

Abcam provides reagents to support development of diagnostics, vaccines, and potential therapeutics.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.